Literature DB >> 21122829

Descemet stripping automated endothelial keratoplasty under failed penetrating keratoplasty: a surgical strategy to minimize complications.

Michael D Straiko1, Mark A Terry, Neda Shamie.   

Abstract

PURPOSE: To report early complications of Descemet stripping automated endothelial keratoplasty (DSAEK) to treat late endothelial failure after penetrating keratoplasty (PK) using a specific surgical strategy.
DESIGN: Retrospective analysis of a prospectively collected dataset.
METHODS: All 17 eyes with a preoperative diagnosis of failed penetrating keratoplasty graft were identified out of a total pool of 793 eyes that had received DSAEK for endothelial dysfunction in a prospective Institutional Review Board-approved study of endothelial keratoplasty. A standard surgical strategy of careful slit-lamp examination and preoperative optical coherence tomography (OCT) to determine optimal DSAEK graft diameter was combined with undersized Descemet stripping and peripheral bed scraping.
RESULTS: A total of 17 eyes in 16 patients were identified. The DSAEK graft size ranged from 7.0 to 8.0 mm, with all DSAEK graft diameters less than or equal to the PK diameter. The average follow-up was 16 months (range 2-38 months). All PK grafts cleared and the visual acuity improved in all patients. There were no cases of pupillary block or primary graft failure. There was 1 dislocation (5.9%). The dislocation occurred in an eye with aniridia, prior trabeculectomy, and scleromalacia with postoperative hypotony from a wound leak.
CONCLUSION: DSAEK for failed PK using DSAEK grafts with a diameter less than or equal to the PK diameter allowed improved vision with a low complication rate. Preoperative OCT of posterior PK contour can aid in graft diameter selection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21122829     DOI: 10.1016/j.ajo.2010.08.017

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Descemet stripping automated endothelial keratoplasty for microcornea.

Authors:  Hiroshi Toshida; Toshihiko Ohta; Akira Murakami; Akira Kobayashi; Kazuhisa Sugiyama
Journal:  Jpn J Ophthalmol       Date:  2012-07-07       Impact factor: 2.447

2.  Descemet membrane endothelial keratoplasty for graft failure following penetrating keratoplasty.

Authors:  Sonja Heinzelmann; Daniel Böhringer; Philipp Eberwein; Thabo Lapp; Thomas Reinhard; Philip Maier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-02-03       Impact factor: 3.117

3.  Ophthalmic transplantology: anterior segment of the eye - part I.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Wanda Romaniuk; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2012-05

4.  Descemet stripping endothelial keratoplasty for a failed penetrating keratoplasty graft in a pseudophakic patient with a toric intraocular lens: a case report.

Authors:  George D Kymionis; George A Kontadakis
Journal:  BMC Ophthalmol       Date:  2013-10-30       Impact factor: 2.209

5.  Outcome of Descemet Stripping Automated Endothelial Keratoplasty in Failed Penetrating Keratoplasty.

Authors:  Abdulrahman S Khairallah
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Apr-Jun

Review 6.  Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies.

Authors:  Mengyuan Liu; Jing Hong
Journal:  J Ophthalmol       Date:  2018-11-15       Impact factor: 1.909

7.  DMEK after penetrating keratoplasty: cohort with DMEK grafts and descemetorhexis larger than full-thickness graft.

Authors:  F A Steindor; J Menzel-Severing; M Borrelli; S Schrader; G Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-05       Impact factor: 3.535

8.  Indications of optical coherence tomography in keratoplasties: literature review.

Authors:  Thiago Trindade Nesi; Daniel Amorim Leite; Fábio Medina Rocha; Marco Antônio Tanure; Pedro Paulo Reis; Eduardo Büchele Rodrigues; Mauro Silveira de Queiroz Campos
Journal:  J Ophthalmol       Date:  2012-10-15       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.